omica.ai logo — Latin America's Biomedical Data Hub, aggregating high-qualit...

omica.ai

Latin America's Biomedical Data Hub, aggregating high-quality datasets for Life Science R&D with an AI-enhanced EMR system linked to a multi-omics biobank.

Founded 2021 Pre-Seed Total: $820.00K Biotechnology

General Information

Company Name omica.ai
Founded Year 2021
Industries Biotechnology
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with omica.ai. To contact omica.ai, visit omica.bio.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does omica.ai compare?

A PDF of omica.ai and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting omica.ai soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About omica.ai

Omica.ai is an innovative startup focusing on Biotechnology, founded in 2021. The company's slogan, "Latin America's Biomedical Data Hub, aggregating high-quality datasets for Life Science R&D with an AI-enhanced EMR system linked to a multi-omics biobank," captures the essence of its mission. Omica.ai's core offering is a platform that aggregates high-quality datasets for Life Science R&D, comprising an AI-enhanced EMR system linked to a multi-omics biobank. Their Pre Seed Round investment of $820.00K on 01 May 2022 saw participation from notable investors including Caffeinated Capital, Axial VC, and Alfredo Andere. With its focus on leveraging data for biomedical advancements, Omica.ai presents a promising venture at the intersection of biotechnology and data analytics.

Business keywords: Biomedical Data, Life Science R&D, AI-enhanced EMR System, Multi-omics Biobank, Latin America, Data Aggregation, High-quality Datasets, Research and Development, Healthcare Innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round $820.00K 3
Caffeinated Capital, Axial VC +1
01 May 2022

omica.ai Alternatives & Competitors

omica.ai vs

BRINGING SCIENCE TO LIFE - Convergence of Food Pharma & Population Genetics

Venture round
109 employees
Biotechnology, Health Care
omica.ai vs
Aptamer Group
Aptamer Group United Kingdom

We develop Optimer® binders to enable innovation across the life science industry.

Post-IPO Equity
38 employees
Biotechnology, Health Care
omica.ai vs

We improve patient lives by unlocking the tissue phenome. In oncology, therapeutic strategies hav...

Venture round
17 employees
Analytics, Biotechnology

FAQ About omica.ai

Latin America's Biomedical Data Hub, aggregating high-quality datasets for Life Science R&D with an AI-enhanced EMR system linked to a multi-omics biobank.
omica.ai was founded in 2021.
omica.ai operates in Biotechnology. Its work centres on Biomedical Data, Life Science R&D, AI-enhanced EMR System and Multi-omics Biobank.
omica.ai has completed 1 funding round, raising a total of $820.00K. The latest funding stage is Pre-Seed.
Top alternatives and competitors to omica.ai include AVESTHAGEN LIMITED, Aptamer Group, Definiens, The Tissue Phenomics Company, Dianox, SeeTrue Technology, LLC. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
omica.ai and AVESTHAGEN LIMITED are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for omica.ai, https://bouncewatch.com/company/omicaai, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes